Jane Street
SLXNW

Jane Street’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Jane Street’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52K Hold
74,910
– – ﹤0.01% 11387
2025
Q4 		$1.95K Hold
74,910
– – ﹤0.01% 10925
2025
Q3 		$2.64K Hold
74,910
– – ﹤0.01% 10627
2025
Q2 		$3.06K Sell
74,910
-392
-0.5% -$21 ﹤0.01% 9453
2025
Q1 		$5.76K Sell
75,302
-419
-0.6% -$26 ﹤0.01% 9231
2024
Q4 		$2.57K Hold
75,721
– – ﹤0.01% 9240
2024
Q3 		$2.4K Buy
+75,721
New +$4.38K ﹤0.01% 9434

Other funds holding SLXNW

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Jane Street's SLXNW Position: Q1 2026 in Review

Jane Street held its Silexion Therapeutics Warrant (SLXNW) position steady in Q1 2026 at 74,910 shares worth $1.52K. The position accounts for ﹤0.01% of the portfolio, ranked #11387.

Jane Street first reported a position in SLXNW in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.76K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q1 2026.

  • Jane Street held 74,910 shares of Silexion Therapeutics Warrant worth $1.52K as of Q1 2026.
  • Jane Street left its Silexion Therapeutics Warrant share count unchanged in Q1 2026.
  • Silexion Therapeutics Warrant made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11387 holding.
  • Jane Street first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 7 quarters since.
  • Jane Street's Silexion Therapeutics Warrant position peaked at $5.76K in Q1 2025.
  • 19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.